You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oligometastatic breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Cairo (radiation, procedure, other)

Recruiting
  • Breast Cancer
  • +2 more
  • Stereotactic Ablative Radiation Therapy
  • +2 more
  • Cairo, Egypt
    National Cancer Institute
Nov 20, 2023

Breast Cancer Trial in São Paulo (radiation, procedure, other)

Recruiting
  • Breast Cancer
  • Radiotherapy
  • +2 more
  • São Paulo, SP, Brazil
    ICESP
Aug 5, 2022

Breast Cancer Stage IV, Oligometastatic Disease Trial (SABR)

Recruiting
  • Breast Cancer Stage IV
  • Oligometastatic Disease
  • SABR
  • Gothenburg, Västra Götalandsregionen, Sweden
    Sahlgrenska University Hospital
Oct 18, 2022

Breast Cancer Metastatic Trial in Beijing, Tai Zhou (standard of care, radiotherapy + standard of care)

Recruiting
  • Breast Cancer Metastatic
  • standard of care
  • radiotherapy + standard of care
  • Beijing, Beijing, China
  • +1 more
Jan 6, 2022

Oligometastatic Breast Carcinoma, Breast Cancer, Metastatic Breast Cancer Trial in United States (Stereotactic body

Recruiting
  • Oligometastatic Breast Carcinoma
  • +5 more
  • Stereotactic body radiotherapy
  • Basking Ridge, New Jersey
  • +6 more
Sep 6, 2022

Metastasis, Metastatic Breast Cancer, Metastatic Prostate Cancer Trial in Spain (To propose a diagnostic test to determine the

Recruiting
  • Metastasis
  • +4 more
  • To propose a diagnostic test to determine the viability of Stereotactic ABlative Radiotherapy (SABR).
  • +2 more
  • Reus, Tarragona, Spain
  • +20 more
Jul 3, 2023

Metastatic Breast Cancer Trial in Germany (Metastases-directed Radiotherapy)

Recruiting
  • Metastatic Breast Cancer
  • Metastases-directed Radiotherapy
  • Mannheim, Baden-Württemberg, Germany
  • +13 more
Apr 27, 2021

TNBC - Triple-Negative Breast Cancer, Triple Negative Breast Cancer, NSCLC Trial in United States (Sterotactic Body

Active, not recruiting
  • TNBC - Triple-Negative Breast Cancer
  • +6 more
  • Sterotactic Body Radiotherapy/SBRT
  • Standard of care
  • Basking Ridge, New Jersey
  • +8 more
Jul 26, 2022

Triple Negative Breast Cancer, Non Small Cell Lung Cancer, Metastatic Breast Cancer Trial in United States (Stereotactic Body

Recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Stereotactic Body Radiotherapy/SBRT
  • Systemic Therapy/Standard of Care
  • Hartford, Connecticut
  • +11 more
Aug 24, 2022

Driven by Disease Biology et/or Immunoactivity (PROMETEO)

Recruiting
  • Oligometastatic Prostate Cancer
    • Aviano, Pordenone, Italy
    • +1 more
    Sep 25, 2023

    Breast Tumor Malignant Female Trial in Amman (Stereotactic Body Radiotherapy)

    Recruiting
    • Breast Neoplasm Malignant Female
    • Stereotactic Body Radiotherapy
    • Amman, Jordan
      King Hussein Cancer Center
    Jun 5, 2020

    Esophageal Squamous Cell Carcinoma, Oligometastatic Disease Trial in Beijing (Esophagectomy)

    Active, not recruiting
    • Esophageal Squamous Cell Carcinoma
    • Oligometastatic Disease
    • Esophagectomy
    • Beijing, China
    • +1 more
    Jul 11, 2023

    Oligometastatic Prostate Cancer Trial (177Lu-PSMA)

    Not yet recruiting
    • Oligometastatic Prostate Cancer
    • (no location specified)
    Sep 26, 2022

    Oligometastatic Squamous Cell Carcinoma of the Head and Neck Trial (Pembrolizumab, stereotattic ablation radiotherapy (SABR))

    Not yet recruiting
    • Oligometastatic Squamous Cell Carcinoma of the Head and Neck
    • (no location specified)
    Apr 14, 2023

    Oligometastatic Prostate Carcinoma Trial in China (ADT combined with abiraterone, neoadjuvant hormone and RT)

    Not yet recruiting
    • Oligometastatic Prostate Carcinoma
    • ADT combined with abiraterone
    • neoadjuvant hormone and RT
    • Hefei, Anhui, China
    • +5 more
    Jan 28, 2023

    Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)

    Not yet recruiting
    • Oligometastatic Prostate Cancer
    • New York, New York
      Columbia University Irving Medical Center / NewYork-Presbyterian
    Jun 14, 2023

    Colorectal Cancer, Oligometastatic Disease Trial in Australia (Local Ablative Therapy, Standard first-line systemic treatment)

    Recruiting
    • Colorectal Cancer
    • Oligometastatic Disease
    • Local Ablative Therapy
    • Standard first-line systemic treatment
    • Albury, New South Wales, Australia
    • +8 more
    May 15, 2023

    Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving

    Recruiting
    • Non-small Cell Lung Cancer
    • Oligometastatic Disease
    • ctDNA testing and whole exome sequencing
    • Guangzhou, Guangdong, China
      Guangdong Lung Cancer Institute, Guangdong Provincial People's H
    Dec 5, 2022

    Unresectable Hepatocellular Carcinoma, Oligometastatic Disease Trial in Beijing (SBRT plus tislelizumab and regorafenib)

    Recruiting
    • Unresectable Hepatocellular Carcinoma
    • Oligometastatic Disease
    • SBRT plus tislelizumab and regorafenib
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Jun 15, 2023

    Oligometastatic Renal Cell Carcinoma Trial in Houston (Pembrolizumab, Radiation therapy)

    Not yet recruiting
    • Oligometastatic Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 21, 2023

    Oligometastatic Prostate Cancer (OMPC) Trial (AAA617)

    Not yet recruiting
    • Oligometastatic Prostate Cancer (OMPC)
    • (no location specified)
    Jul 3, 2023

    Non Small Cell Lung Cancer Trial in Sweden (Standard systemic therapy + radiotherapy, Standard systemic therapy)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Standard systemic therapy + radiotherapy
    • Standard systemic therapy
    • Gothenburg, Sweden
    • +5 more
    Nov 17, 2023

    Treatment Trial in Shanghai (ADT, SBRT)

    Recruiting
    • Treatment
    • Shanghai, Shanghai, China
      Changhai hospital
    Aug 9, 2022

    SBRT for Oligometastatic Castration-Refractory Prostate Cancer

    Completed
    • Prostate Cancer
    • SBRT
    • Rochester, Minnesota
      Mayo Clinic
    Aug 23, 2022

    Prostate Cancer Trial ([177Lu]Lu-PSMA I&T, Stereotactic Radiotherapy)

    Not yet recruiting
    • Prostate Cancer
    • [177Lu]Lu-PSMA I&T
    • Stereotactic Radiotherapy
    • (no location specified)
    May 30, 2023